Outset Medical (OM) Cost of Revenue (2019 - 2026)

Outset Medical (OM) has 8 years of Cost of Revenue data on file, last reported at $15.8 million in Q1 2026.

• On a quarterly basis, Cost of Revenue fell 15.62% year-over-year to $15.8 million in Q1 2026; TTM through Mar 2026 was $69.8 million, a 5.49% decrease from a year earlier, with the FY2025 full-year figure at $72.7 million, down 3.2% from the prior year.
• Cost of Revenue for Q1 2026 stood at $15.8 million, down from $16.6 million in the prior quarter.
• Over the last five years, Cost of Revenue for OM reached as high as $28.3 million in Q2 2023 and fell as low as $15.8 million in Q1 2026.
• Historically, Cost of Revenue has averaged $21.3 million across 5 years, with a median of $20.0 million in 2024.
• Across the five-year window, Cost of Revenue jumped 33.19% in 2023 and tumbled 37.87% in 2024, its largest moves.
• Year by year, Cost of Revenue stood at $26.7 million in 2022, then retreated by 14.73% to $22.8 million in 2023, then dropped by 17.88% to $18.7 million in 2024, then dropped by 11.1% to $16.6 million in 2025, then fell by 5.26% to $15.8 million in 2026.
• Per Business Quant data, the three most recent Cost of Revenue figures were $15.8 million in Q1 2026, $16.6 million in Q4 2025, and $17.8 million in Q3 2025.